FNDC5 and Other metabolic disease: In line with previous work (McCormick, King, Notley, Fujii, Boulay, Sigal, Amano, & Kenny, 2022), the fact that irisin levels were not significantly different between older adults with and without HTN or T2D suggests that age‐related declines in irisin may be independent of metabolic disease status.